{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:58:24Z","timestamp":1790974704565,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":3273,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.bbadis.2004.03.007","type":"journal-article","created":{"date-parts":[[2004,4,23]],"date-time":"2004-04-23T09:53:05Z","timestamp":1082713985000},"page":"219-228","source":"Crossref","is-referenced-by-count":108,"title":["N-Octyl-\u03b2-valienamine up-regulates activity of F213I mutant \u03b2-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease"],"prefix":"10.1016","volume":"1689","author":[{"given":"Hou","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ohsaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruaki","family":"Ninomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyako","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikatsu","family":"Eto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichiro","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miwa","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiko","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Higaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Nanba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousaku","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2004.03.007_BIB1","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"2641","article-title":"Gaucher disease","author":"Beutler","year":"2001"},{"key":"10.1016\/j.bbadis.2004.03.007_BIB2","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2014macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2004.03.007_BIB3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1542\/peds.96.4.629","article-title":"Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase","volume":"96","author":"Rosenthal","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbadis.2004.03.007_BIB4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0268-960X(98)90023-6","article-title":"Enzyme therapy for Gaucher disease: the first 5 years","volume":"12","author":"Grabowski","year":"1998","journal-title":"Blood Rev."},{"key":"10.1016\/j.bbadis.2004.03.007_BIB5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1096-8628(19970711)71:1<16::AID-AJMG3>3.0.CO;2-O","article-title":"Gaucher disease: enzyme therapy in the acute neuronopathic variant","volume":"71","author":"Prows","year":"1997","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbadis.2004.03.007_BIB6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ana.410420412","article-title":"Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease","volume":"42","author":"Schiffmann","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2004.03.007_BIB7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s004310000630","article-title":"Improvement of neurological symptoms by enzyme replacement therapy for Gaucher disease type IIIb","volume":"160","author":"Aoki","year":"2001","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.bbadis.2004.03.007_BIB8","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2004.03.007_BIB9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1010335505357","article-title":"Inhibition of substrate synthesis as a strategy for glycolipids lysosomal storage disease therapy","volume":"24","author":"Platt","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2004.03.007_BIB10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/4801","article-title":"Accelerated transport and maturation of lysosomeal \u03b1-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor","volume":"5","author":"Fan","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2004.03.007_BIB11","first-page":"228","article-title":"Galactonojirimycin derivatives restore mutant human \u03b2-galactosidase activities expressed in fibroblasts from enzyme-deficient knockout mouse","volume":"23","author":"Tominaga","year":"2000","journal-title":"Brain Develop."},{"key":"10.1016\/j.bbadis.2004.03.007_BIB12","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S \u03b2-glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2004.03.007_BIB13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0960-894X(96)00146-1","article-title":"Synthesis of potent \u03b2-d-glucocerebrosidase inhibitors: N-alkyl-\u03b2-valienamines","volume":"6","author":"Ogawa","year":"1996","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbadis.2004.03.007_BIB14","doi-asserted-by":"crossref","first-page":"15912","DOI":"10.1073\/pnas.2536657100","article-title":"Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis","author":"Matsuda","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2004.03.007_BIB15","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0968-0896(98)00143-6","article-title":"Chemical modification of \u03b2-glucocerebrosidase inhibitor N-octyl-\u03b2-valienamine: synthesis and biological evaluation of N-alkanoyl and N-alkyl derivatives","volume":"6","author":"Ogawa","year":"1998","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbadis.2004.03.007_BIB16","first-page":"381","article-title":"Preclinical research of a new therapy for Gaucher's disease with F213I mutation","volume":"20","author":"Lin","year":"2003","journal-title":"Zhonghua YiXue YiChuan Xue ZaZhi"},{"key":"10.1016\/j.bbadis.2004.03.007_BIB17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0009-8981(83)90097-9","article-title":"Determination of Gaucher's disease phenotypes with monoclonal antibody","volume":"131","author":"Ginns","year":"1983","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbadis.2004.03.007_BIB18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0387-7604(98)00035-7","article-title":"Increased expression of \u03b2-hexosaminidase \u03b1 chain in cultured skin fibroblasts from patients with carbohydrate-deficient glycoprotein syndrome type I","volume":"20","author":"Ichisaka","year":"1998","journal-title":"Brain Develop."},{"key":"10.1016\/j.bbadis.2004.03.007_BIB19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1023\/A:1022553819241","article-title":"Clinical and molecular characteristics of Japanese Gaucher disease","volume":"24","author":"Eto","year":"1999","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbadis.2004.03.007_BIB20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0009-9120(87)90010-5","article-title":"Effect of a heat-stable factor in human placenta on glucosylceramidase, glucosylsphingosine glucosyl hydrolase, and acid \u03b2-glucosidase activities","volume":"20","author":"Vaccaro","year":"1987","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bbadis.2004.03.007_BIB21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1399-0004.1988.tb03465.x","article-title":"Km mutant of acid \u03b1-glucosidase in a case of cardiomyopathy without signs of skeletal muscle involvement","volume":"33","author":"Suzuki","year":"1988","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bbadis.2004.03.007_BIB22","doi-asserted-by":"crossref","first-page":"12391","DOI":"10.1073\/pnas.221181998","article-title":"Accumulation of cholera toxin and GM1 ganglioside in the early endosome of Niemann\u2013Pick C1-deficient cells","volume":"98","author":"Sugimoto","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2004.03.007_BIB23","doi-asserted-by":"crossref","first-page":"7069","DOI":"10.1074\/jbc.M004129200","article-title":"Hrs interacts with sorting nexin 1 and regulates degradation of epidermal growth factor receptor","volume":"276","author":"Chin","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2004.03.007_BIB24","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1006\/bbrc.1994.1612","article-title":"Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of ceramide in vivo","volume":"200","author":"Klein","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2004.03.007_BIB25","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/hmg\/9.7.1087","article-title":"Alleviation of neuronal ganglioside storage does not improve the clinical course of the Niemann\u2013Pick C disease mouse","volume":"9","author":"Liu","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2004.03.007_BIB26","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/hmg\/6.6.887","article-title":"Expression of mutated glucocerebrosidase alleles in human cells","volume":"6","author":"Pasmanik-Chor","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2004.03.007_BIB27","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1079181","article-title":"EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin","volume":"299","author":"Oda","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2004.03.007_BIB28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/(SICI)1096-9896(199908)188:4<407::AID-PATH377>3.0.CO;2-Z","article-title":"Intracellular transport of acid \u03b2-glucosidase and lysosome-associated membrane proteins is affected in Gaucher's disease (G202R mutation)","volume":"188","author":"Zimmer","year":"1999","journal-title":"J. Pathol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443904000511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443904000511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T03:24:07Z","timestamp":1734319447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443904000511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0925443904000511"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2004.03.007","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}